EN DE
Watch Sonmez Pamuklu Sanayii AS for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Sonmez Pamuklu Sanayii AS (SNPAM) fair value: what the stock is really worth

As of Oct 28, 2026: fair value (intrinsic value) of Sonmez Pamuklu Sanayii AS stock TRY 3.04, price TRY 16.50, upside -81.6%, quality 27 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical TR · ISIN TRASNPAM91B0

SP Sonmez Pamuklu Sanayii AS logo Thin data Oct 30, 2026

Sonmez Pamuklu Sanayii AS

SNPAM · IS
Very expensive, weak quality

Our calculation puts a fair price 82% below what the stock costs today.

Low debt
Generates free cash flow
Mixed Growth (revenue 5y +63.7 %/yr in TRY)
Revenue last quarter 19% below a year ago.
Fair value 3.04 TRY · Strongly overvalued (−81.6%)
Quality 27/100
Loss-making · -31.6% net margin (TTM)
Trails peers (2/12)
Narrow moat 19/100
Thin data
⚠ Dilution⚠ Small free float

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

66.68 TRY 2.42 TRY Fair Value 3.04 TRY Aug 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year. As of Oct 30, 2026.

How to read this chart

60‑month range 2.42 TRY – 66.68 TRY · fair‑value band 2.73 TRY – 3.60 TRY · the 16.50 TRY price screens above the 3.04 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 30, 2026.

Follow Sonmez Pamuklu Sanayii AS in your weekly email

Every Wednesday you see whether Sonmez Pamuklu Sanayii AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Sönmez Pamuklu Sanayii A.S. engages in the manufacturing and dyeing of artificial, synthetic, and blended textile yarns and fabrics in Turkey. It is also involved in real estate leasing activities. Sönmez Pamuklu Sanayii A.S. was founded in 1981 and is based in Bursa, Turkey.

Stock analysis

Sonmez Pamuklu Sanayii AS (SNPAM) currently trades at 16.50 TRY, while our model-based Fair Value estimate is 3.04 TRY, 81.6% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of 12.50 TRY per share, and 0 of the 10 models we run sit above the 16.50 TRY price.

Bear case: the Multiples group reads lowest at 1.39 TRY, and 10 of the 10 models stay below the price. Data coverage for this calculation is low.

Scenario range: 2.73 TRY (bear) to 3.60 TRY (bull), the price of 16.50 TRY sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 27/100 (below-average quality), in the Consumer Cyclical sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Sonmez Pamuklu Sanayii AS reported revenue of 854M TRY in FY2025 versus 166M TRY in FY2021, a compound +50.6%/yr. Reported net income was −338M TRY in FY2025.

Key figures

Market cap 12.8B TRY (≈ $255M) Micro · P/E ratio 75.0 · P/S ratio 8.48 · EPS (TTM) −0.6100 TRY · Net margin −31.6% · Return on equity −3.2% · Return on assets (EBIT) 7.5% · Operating margin 15.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 19 out of 100 (medium confidence).

What moves the price

The share trades about 38% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at −17% fair-value upside, at −82%, SNPAM screens richer than that median.

Fair Value models

The price assumes far more growth than our models allow for, so the models scatter widely (1.39 TRY to 12.50 TRY). Read the Fair Value as a cautious anchor, not a price target; the Growth Forecast section shows what the price assumes.
Bear 2.73 TRY Fair Value 3.04 TRY Bull 3.60 TRY
Price 16.50 TRY · Upside -81.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 3.78 TRY 4.50 TRY 5.61 TRY 82
Growth DCF 3.83 TRY 4.51 TRY 5.47 TRY 80
5Y EBITDA Exit 2.55 TRY 2.99 TRY 3.58 TRY 77
All 10 models by family
DCF Models
FCF DCF 3.78 TRY 4.50 TRY 5.61 TRY 82
5Y Revenue Exit 2.89 TRY 3.57 TRY 4.56 TRY 74
5Y EBITDA Exit 2.55 TRY 2.99 TRY 3.58 TRY 77
10Y Revenue Exit 3.33 TRY 3.78 TRY 4.23 TRY 68
10Y EBITDA Exit 3.21 TRY 3.52 TRY 3.80 TRY 70
Multiples
EV/EBITDA 1.02 TRY 1.39 TRY 1.76 TRY 67
EV/Revenue 1.75 TRY 2.54 TRY 3.33 TRY 53
Asset-Based
NCAV (Graham) 9.33 TRY 12.50 TRY 18.65 TRY 54
Growth DCF
Growth DCF 3.83 TRY 4.51 TRY 5.47 TRY 80
Rev-Margin DCF 2.89 TRY 3.69 TRY 4.72 TRY 74

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 27/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 1
How much profit the company makes from its sales and capital
Quality Growth 8
Are margins and returns getting better?
Cashflow 86
Do the profits arrive as real cash?
Financial strength 76
Debt, balance sheet and risk of trouble
Investment 15
Does it invest with discipline instead of growing at any price?
Low Volatility 74
How calm the share price moves, does not count
Momentum 15
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 53/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−17.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+35.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+63.7%
Start year 2020 (pandemic). Over 10 years: +40.2% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
17.0% (2020) → −7.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+44.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Turkey: IMF forecast 19.3% a year to 2030, 28.5% from 2016 to 2025) that is about +21.0% a year for the price.

SNPAM screens overvalued: fair value 82% below the price. Compare with Tongkun Group →

Compare Sonmez Pamuklu Sanayii AS with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 340 stocks

Beats the industry median on 1/10 measures
Overall it trails its industry peers.
Valuation
Quality Score 27 · Bottom 25%
Fair Value upside −81.6% · Bottom 25%
Profitability
Return on assets −4.0% · Bottom 25%
Net margin (12 months) −31.6% · Bottom 25%
Operating margin (12 months) 15.1% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) −18.9% · Bottom 25%

Valuation Multiplesvs Textile Manufacturing median · lower = cheaper

P/E (12 months) 75.0× · Priciest 25%
P/B 1.75× · Pricier than median
P/S (12 months) 16.80× · Priciest 25%
Price / free cash flow 54.6× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 13
FUTURE (revenue growth)0 · sector 37
PAST (return on equity)0 · sector 17
HEALTH (low debt)100 · sector 95
DIVIDEND (yield)0 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Sonmez Pamuklu Sanayii AS Fair Value". https://www.fairvalue-calculator.com/stock/SNPAM

Frequently asked questions

Is Sonmez Pamuklu Sanayii AS (SNPAM) overvalued or undervalued?
As of Oct 30, 2026, our model estimates a fair value of 3.04 TRY versus a price of 16.50 TRY, about −82% upside (overvalued).
What is the fair value of SNPAM?
Our model-based fair value for Sonmez Pamuklu Sanayii AS is 3.04 TRY (as of Oct 30, 2026), built from audited fundamentals. The current price: 16.50 TRY.
What is the quality score of SNPAM?
Sonmez Pamuklu Sanayii AS has a Quality Score of 27/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sonmez Pamuklu Sanayii AS (SNPAM)?
Our model-based price target is the fair value of 3.04 TRY (as of Oct 30, 2026) from 10 valuation models. Cautious scenario 2.73 TRY, optimistic scenario 3.60 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Sonmez Pamuklu Sanayii AS stock forecast for 2026?
Our models put fair value at 3.04 TRY, about −82% upside versus a price of 16.50 TRY (overvalued). Cautious scenario 2.73 TRY, optimistic scenario 3.60 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Sonmez Pamuklu Sanayii AS (SNPAM)?
Sonmez Pamuklu Sanayii AS reported trailing-twelve-month revenue of about 759M TRY (latest available figure, as of Oct 30, 2026).
What growth is priced into Sonmez Pamuklu Sanayii AS (SNPAM)?
For today's price to be fair in a discounted-cash-flow model, Sonmez Pamuklu Sanayii AS would have to grow free cash flow by +44.4 % per year for five years (discount rate 15.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +63.7 % per year. As of Oct 30, 2026.
What discount rate (WACC) does the fair value of SNPAM use?
Our models discount Sonmez Pamuklu Sanayii AS at 15.7 %: a base by market capitalisation (micro), damped by beta 0.40, country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sonmez Pamuklu Sanayii AS that is +44.4 % per year a year over ten years, using the same discount rate (15.7 %) and the same formula as our fair value.
How much growth has Sonmez Pamuklu Sanayii AS (SNPAM) delivered so far?
Over the past 5 years revenue at Sonmez Pamuklu Sanayii AS grew +63.7 % a year. The price currently implies +44.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Sonmez Pamuklu Sanayii AS (SNPAM) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Sonmez Pamuklu Sanayii AS (+44.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Sonmez Pamuklu Sanayii AS (SNPAM)?
The free-cash-flow yield on the price is 1.83 %: that much free cash flow Sonmez Pamuklu Sanayii AS produces per unit of market value. When it exceeds the discount rate of our models (15.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Sonmez Pamuklu Sanayii AS (SNPAM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sonmez Pamuklu Sanayii AS it is 3.04 TRY per share (as of Oct 30, 2026), against a price of 16.50 TRY. It is the blended result of 10 valuation models (cash flow, earnings, asset, dividend).
Is Sonmez Pamuklu Sanayii AS stock overvalued or undervalued in 2026?
As of Oct 30, 2026, SNPAM trades above its calculated fair value: price 16.50 TRY, fair value 3.04 TRY, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SNPAM?
No. The price is what the market pays today (16.50 TRY); the fair value is what the company's own numbers justify (3.04 TRY). For Sonmez Pamuklu Sanayii AS the two are 13.47 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Sonmez Pamuklu Sanayii AS worth?
The market values Sonmez Pamuklu Sanayii AS at about 12.8B TRY (market capitalisation, as of Oct 30, 2026). Per share that is 16.50 TRY; our models calculate a fair value of 3.04 TRY per share.
What do the bullish and bearish scenarios say about SNPAM?
Our models span a range for Sonmez Pamuklu Sanayii AS: cautious scenario 2.73 TRY, base 3.04 TRY, optimistic 3.60 TRY per share (as of Oct 30, 2026, price 16.50 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of SNPAM?
Sonmez Pamuklu Sanayii AS trades at a price-to-earnings ratio of 75.0 (as of Oct 30, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 3.04 TRY is built from several models across several years. Other multiples: P/B 1.8, P/S 16.8.
How solid is the balance sheet of Sonmez Pamuklu Sanayii AS (SNPAM)?
Balance-sheet figures for Sonmez Pamuklu Sanayii AS (as of Oct 30, 2026): return on equity −3.2%. They feed the Quality Score of 27/100, which measures business quality independently of the share price.
How far is SNPAM from its 52-week high?
Sonmez Pamuklu Sanayii AS trades at 16.50 TRY, about 38% below its 52-week high of 26.76 TRY and 2% above the low of 16.18 TRY (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of 3.04 TRY is for.
Which stocks are comparable to Sonmez Pamuklu Sanayii AS?
From the same area (Consumer Cyclical) we also value Tongkun Group, Inner Mongolia ERDOS Resources Co, K.P.R. Mill Limited, HMT (Xiamen) New Technical Materials Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sonmez Pamuklu Sanayii AS stock attractive at the current price?
The data as of Oct 30, 2026: price 16.50 TRY, calculated fair value 3.04 TRY (−82%), Quality Score 27/100, from 10 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SNPAM calculated?
We run Sonmez Pamuklu Sanayii AS through 10 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 3.04 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.1 % above its aggregate fair value. Sonmez Pamuklu Sanayii AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sonmez Pamuklu Sanayii AS (SNPAM)?
The closing price on Oct 28, 2026 was 16.50 TRY. Our model-based fair value is 3.04 TRY, about −82% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sonmez Pamuklu Sanayii AS right now?
The price sits above even our optimistic bull case (3.60 TRY). The favourable scenario is already priced in. Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Sonmez Pamuklu Sanayii AS

How large is the market capitalisation of Sonmez Pamuklu Sanayii AS (SNPAM)?
The market capitalisation of Sonmez Pamuklu Sanayii AS is 12.8B TRY (≈ $255M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sonmez Pamuklu Sanayii AS (SNPAM)?
The price-to-sales ratio of Sonmez Pamuklu Sanayii AS is 8.48 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sonmez Pamuklu Sanayii AS (SNPAM)?
Earnings per share at Sonmez Pamuklu Sanayii AS are −0.6100 TRY (price ÷ EPS = P/E 75.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Sonmez Pamuklu Sanayii AS (SNPAM)?
The net margin of Sonmez Pamuklu Sanayii AS is −31.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sonmez Pamuklu Sanayii AS (SNPAM)?
The return on equity (ROE) of Sonmez Pamuklu Sanayii AS is −3.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sonmez Pamuklu Sanayii AS (SNPAM)?
On an EBIT basis the return on assets of Sonmez Pamuklu Sanayii AS is 7.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sonmez Pamuklu Sanayii AS (SNPAM)?
The operating margin of Sonmez Pamuklu Sanayii AS is 15.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sonmez Pamuklu Sanayii AS (SNPAM)?
Revenue at Sonmez Pamuklu Sanayii AS is growing −18.9% versus a year earlier (3y avg +35.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sonmez Pamuklu Sanayii AS (SNPAM)?
Earnings per share at Sonmez Pamuklu Sanayii AS are growing −15.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Sonmez Pamuklu Sanayii AS (SNPAM) carry?
The net debt of Sonmez Pamuklu Sanayii AS is 34.0M TRY (fiscal year 2023, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Sonmez Pamuklu Sanayii AS in the live analysis

One click puts Sonmez Pamuklu Sanayii AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.